New device zaps migraines away in Drug-Resistant patients

NCT ID NCT06450444

Recruiting now Symptom relief Sponsor: Salvia BioElectronics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests a device called the PRIMUS System that uses mild electrical pulses to stimulate nerves in the head and neck. It is for people with chronic or frequent migraine who have not gotten relief from at least three preventive medicines. The goal is to see if the device safely reduces the number of migraine days per month. About 110 adults will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC MIGRAINE HIGH FREQUENCY EPISODIC MIGRAINE

Contacts and locations

Locations

AZ Delta
RECRUITING

Roeselare, West Vlaanderen, Belgium
AZ Groeninge
RECRUITING

Kortrijk, West Vlaanderen, Belgium
AZ Oostende
RECRUITING

Ostend, West Vlaanderen, Belgium
AZ Sint Jan Brugge
RECRUITING

Bruges, West Vlaanderen, 8000, Belgium
Erasmus MC Rotterdam
RECRUITING

Rotterdam, Netherlands
Genesis Research Services
TERMINATED

Broadmeadow, New South Wales, NSW, 2292, Australia
Jessa Hasselt
RECRUITING

Hasselt, Limburg, 3500, Belgium
Private Practice Dr. Sava
ACTIVE_NOT_RECRUITING

Saint-Nicolas, Liège, Belgium
Resolve Pain
TERMINATED

Buderim, Queensland, 4556, Australia
St. Antonius Nieuwegein
RECRUITING

Nieuwegein, Netherlands
ZAS Antwerpen, Campus Sint-Augustinus
RECRUITING

Wilrijk, Antwerpen, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.